A lap behind the pace car

Ebb & Flow

NEW TO MARKET: BioReliance (BREL) raised $31.5 million through the sale of 2.1 million shares at $15. The company, which specializes in non-clinical testing and contract manufacturing services, filed to sell the shares at $12-$14. BREL was founded in 1947 as Microbiological Associates Inc. BREL

Read the full 490 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE